|
|
Volumn 32, Issue 7, 2000, Pages 1709-1710
|
|
Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISOLONE;
TACROLIMUS;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG MECHANISM;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
AZATHIOPRINE;
CHINA;
CYCLOSPORINE;
DRUG MONITORING;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID;
PREDNISONE;
TACROLIMUS;
TIME FACTORS;
|
|
EID: 0033664547
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(00)01405-6 Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
